logo
Confluent Announces First Quarter 2025 Financial Results

Confluent Announces First Quarter 2025 Financial Results

Business Wire30-04-2025

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced financial results for its first quarter of 2025, ended March 31, 2025.
'Confluent started the year with solid momentum, achieving subscription revenue growth of 26% year over year,' said Jay Kreps, co-founder and CEO, Confluent. 'Our growth at scale amid heightened macroeconomic uncertainty demonstrates the mission-critical nature of data streaming and our significant product leadership. We remain laser-focused on enabling our customers to cost-efficiently build next-generation applications and win in the age of AI.'
'We are pleased with our robust first quarter results, demonstrating the resilience of our business and our ability to capture our market opportunity,' said Rohan Sivaram, CFO, Confluent. 'These results underscore the strength of our data streaming platform, the strategic value of our multi-cloud, multi-data destination, and multi-deployment approach, as well as the flexibility of our well-diversified growth strategy.'
A reconciliation of forward-looking non-GAAP operating margin, adjusted free cash flow margin and non-GAAP net income per diluted share to the most directly comparable GAAP measures is not available without unreasonable effort, as certain items cannot be reasonably predicted because of their high variability, complexity and low visibility. In particular, the measures and effects of our stock-based compensation-related charges, which include stock-based compensation expenses, employer payroll taxes on employee stock transactions, and amortization of stock-based compensation capitalized in internal-use software, are directly impacted by the timing of employee stock transactions and unpredictable fluctuations in our stock price, which we expect to have a significant impact on our future GAAP financial results.
Conference Call Information
Confluent will host a video webcast to discuss the company's first quarter 2025 results as well as its financial outlook today at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. Open to the public, investors may access the webcast, earnings press release, supplemental financial information, and investor presentation on Confluent's investor relations website at investors.confluent.io before the commencement of the webcast. A replay of the webcast will also be accessible from Confluent's investor relations website a few hours after the conclusion of the live event.
Confluent uses its investor relations website and may use its X (Twitter), LinkedIn, and Facebook accounts as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Forward-Looking Statements
This press release and the earnings call referencing this press release contain forward-looking statements including, among other things, statements regarding (i) our financial outlook, including expected subscription revenue, Confluent Cloud revenue, non-GAAP operating margin, free cash flow margin, adjusted free cash flow margin, non-GAAP net income per share, revenue mix, including Confluent Cloud subscription revenue mix, revenue run rates, Confluent Cloud and data streaming platform growth, adoption and traction, operating margins and margin improvements, targeted or anticipated gross and operating margin levels, earnings per share levels and improvements, in-product optimizations of Confluent Cloud, continued business momentum, and expected revenue, (ii) our market and category leadership position, (iii) our expectations and trends relating to growth of our Data Streaming Platform products, (iv) rates of Confluent Cloud consumption and demand for and retention of data streaming platforms like Confluent, (v) customer growth, retention and engagement, and expansion of customers into new use cases, (vi) ability for Confluent Cloud to provide cost savings for users and customers, including lower total cost of ownership, and our ability to drive return-on-investment-based expansions for our customers and capture the open-source conversion opportunity, (vii) increased adoption of our offerings and fully managed solutions for data streaming in general, including from customers building generative AI applications, (viii) dependence of businesses on data in motion, (ix) growth in and growth rate of revenue, customers, dollar-based net retention rate, and gross retention rate, (x) our ability to increase engagement of customers for Confluent and expand customer cohorts, (xi) our market opportunity and our ability to capture our market opportunity, (xii) the resilience of our business, (xiii) our go-to-market strategy, (xiv) our product differentiation and market acceptance of our products, (xv) our strategy and expected results and market acceptance for our Flink offering, Tableflow, Freight Clusters, and our other Data Streaming Platform offerings, (xvi) our expectations for market acceptance, direction and growth of stream processing, its potential to accelerate adoption of our platform and growth of our business, and our ability and positioning to capture this market, (xvii) our expectations of meeting near-term and mid-term financial targets, (xviii) our expectations regarding the generative AI landscape and our offerings, (xix) our expectations of relevance of certain key financial and operating metrics, (xx) our ability to drive long-term growth, (xxi) our expectations regarding the impact of our offerings, including WarpStream and Freight Clusters, (xxii) our expectations regarding our growth strategies and our partner ecosystem, including our Confluent OEM Program, (xxiii) our ability to offer pricing and packaging that fit the full range of Kafka use cases, and (xxiv) our overall future prospects. The words 'believe,' 'may,' 'will,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'expect,' 'seek,' 'plan,' 'project,' 'target,' 'looking ahead,' 'look to,' 'move into,' and similar expressions are intended to identify forward-looking statements. Forward-looking statements represent our current beliefs, estimates and assumptions only as of the date of this press release and information contained in this press release should not be relied upon as representing our estimates as of any subsequent date. These forward-looking statements are subject to risks, uncertainties, and assumptions. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Risks include, but are not limited to: (i) our limited operating history, including in uncertain macroeconomic environments, (ii) our ability to sustain and manage our rapid growth, (iii) our ability to increase consumption of our offerings, including by existing customers and through the acquisition of new customers, including by addressing customer consumption preferences, successfully adding new features and functionality to our offerings, and partnering with our customers to help them realize increased value in Confluent in an efficient and sustainable manner, (iv) our ability to successfully execute our go-to-market strategy and initiatives, (v) our ability to attract new customers and successfully ramp their consumption of our offerings, as well as retain and sell additional features and services to our existing customers, (vi) uncertain macroeconomic conditions, including high inflation, high interest rates, bank failures, global tariffs, taxes on multinational companies, geopolitical events, recessionary risks, and exchange rate fluctuations, (vii) our ability to achieve profitability and improve margins annually, by our expected timelines or at all, (viii) the estimated addressable market opportunity for our Data Streaming Platform, and our ability to capture our share of that market opportunity, (ix) shifts in certain customers' data streaming strategies, (x) our ability to compete effectively in an increasingly competitive market, (xi) our ability to attract, ramp, and retain highly qualified personnel, and the impacts of attrition and related challenges, (xii) breaches in our security measures, intentional or accidental cybersecurity incidents or unauthorized access to our platform, our data, or our customers' or other users' personal data, (xiii) our reliance on third-party cloud-based infrastructure to host Confluent Cloud, (xiv) public sector budgetary cycles and funding reductions or delays, or shifts in procurement strategies, (xv) our ability to accurately forecast our future performance, business and growth, and (xvi) general market, political, economic, and business conditions. These risks are not exhaustive. Further information on these and other risks that could affect Confluent's results is included in our filings with the Securities and Exchange Commission ('SEC'), including our Annual Report on Form 10-K for the year ended December 31, 2024, and our future reports that we may file from time to time with the SEC. Additional information will be made available in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 that will be filed with the SEC, which should be read in conjunction with this press release and the financial results included herein. Confluent assumes no obligation to, and does not currently intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP Financial Measures
This press release includes the following non-GAAP financial measures: non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses (research and development, sales and marketing, and general and administrative), non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP net income, non-GAAP net income per share, free cash flow, free cash flow margin, adjusted free cash flow, and adjusted free cash flow margin. We use these non-GAAP financial measures and other key metrics internally to facilitate analysis of our financial and business trends and for internal planning and forecasting purposes. We believe these non-GAAP financial measures, when taken collectively, may be helpful to investors because they provide consistency and comparability with past financial performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. However, non-GAAP financial measures have limitations as an analytical tool and are presented for supplemental informational purposes only. They should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies, including companies in our industry, may report non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses (research and development, sales and marketing, general and administrative), non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP net income, non-GAAP net income per share, free cash flow, free cash flow margin, adjusted free cash flow, adjusted free cash flow margin, or similarly titled measures but calculate them differently, which reduces their usefulness as comparative measures. Further, free cash flow and adjusted free cash flow are not substitutes for cash used in operating activities. The utility of free cash flow and adjusted free cash flow are limited as such measures do not reflect our future contractual commitments and do not represent the total increase or decrease in our cash balance for any given period. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures, as presented below.
We define non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses (research and development, sales and marketing, and general and administrative), non-GAAP operating income (loss), non-GAAP operating margin, non-GAAP net income, and non-GAAP net income per share as the respective GAAP measures, adjusted for, as applicable, stock-based compensation-related charges which include stock-based compensation expense, employer taxes on employee stock transactions and amortization of stock-based compensation capitalized in internal-use software; amortization of acquired intangibles; acquisition-related expenses; amortization of debt issuance costs; and income tax effects associated with these adjustments as well as the non-recurring income tax expense or benefit associated with acquisitions and income tax benefit from the release of a valuation allowance on certain deferred tax assets. Non-GAAP gross margin and non-GAAP operating margin are defined as non-GAAP gross profit and non-GAAP operating income (loss) as a percentage of revenue, respectively.
We define free cash flow as net cash used in operating activities less capitalized internal-use software costs and capital expenditures and free cash flow margin as free cash flow as a percentage of revenue. We define adjusted free cash flow as free cash flow excluding the non-recurring impact from a change to timing of certain cash compensation payments and adjusted free cash flow margin as adjusted free cash flow as a percentage of revenue. We believe that free cash flow, free cash flow margin, adjusted free cash flow, and adjusted free cash flow margin are useful indicators of liquidity that provide information to management and investors about the performance of core operations and future ability to generate cash that can be used for strategic opportunities or investing in our business.
Definition
Customers with $100,000 or greater in annual recurring revenue ('ARR') represent the number of customers that contributed $100,000 or more in ARR as of period end. We define ARR as (1) with respect to Confluent Platform customers, the amount of revenue to which our customers are contractually committed over the following 12 months assuming no increases or reductions in their subscriptions, and (2) with respect to Confluent Cloud and WarpStream customers, the amount of revenue that we expect to recognize from such customers over the following 12 months, calculated by annualizing actual consumption of Confluent Cloud and WarpStream in the last three months of the applicable period, assuming no increases or reductions in usage rate. Services arrangements are excluded from the calculation of ARR. For purposes of determining our customer count, we treat all affiliated entities with the same parent organization as a single customer and include pay-as-you-go customers. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity.
About Confluent
Confluent is the data streaming platform that is pioneering a fundamentally new category of data infrastructure that sets data in motion. Confluent's cloud-native offering is the foundational platform for data in motion – designed to be the intelligent connective tissue enabling real-time data, from multiple sources, to constantly stream across the organization. With Confluent, organizations can meet the new business imperative of delivering rich, digital front-end customer experiences and transitioning to sophisticated, real-time, software-driven backend operations.
Confluent, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
(unaudited)
Three Months Ended March 31,
2025
2024
Revenue:
Subscription
$
260,910
$
206,902
Services
10,210
10,335
Total revenue
271,120
217,237
Cost of revenue:
Subscription (1)
56,847
48,355
Services (1)
12,271
12,866
Total cost of revenue
69,118
61,221
Gross profit
202,002
156,016
Operating expenses:
Research and development (1)
116,801
97,571
Sales and marketing (1)
146,259
131,352
General and administrative (1)
40,120
38,444
Total operating expenses
303,180
267,367
Operating loss
(101,178
)
(111,351
)
Other income, net
20,410
20,850
Loss before income taxes
(80,768
)
(90,501
)
Provision for (benefit from) income taxes
(13,194
)
2,466
Net loss
$
(67,574
)
$
(92,967
)
Net loss per share, basic and diluted
$
(0.20
)
$
(0.30
)
Weighted-average shares used to compute net loss per share, basic and diluted
335,755,902
314,203,181
(1) Includes stock-based compensation-related charges as follows:
Three Months Ended March 31,
2025
2024
Cost of revenue - subscription
$
8,708
$
7,905
Cost of revenue - services
1,867
2,718
Research and development
43,835
41,424
Sales and marketing
32,757
35,780
General and administrative
14,410
15,158
Total stock-based compensation-related charges
$
101,577
$
102,985
Expand
Confluent, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)
Three Months Ended March 31,
2025
2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$
(67,574
)
$
(92,967
)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization
6,605
4,311
Net accretion of discounts on marketable securities
(6,847
)
(10,396
)
Amortization of debt issuance costs
945
953
Amortization of deferred contract acquisition costs
13,931
12,762
Non-cash operating lease costs
1,075
885
Stock-based compensation, net of amounts capitalized
92,575
95,322
Deferred income taxes
(17,338
)
615
Other
454
849
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable
15,414
29,360
Deferred contract acquisition costs
(10,410
)
(9,732
)
Prepaid expenses and other assets
1,515
(1,929
)
Accounts payable
(1,274
)
(4,932
)
Accrued expenses and other liabilities
(49,828
)
(43,752
)
Operating lease liabilities
(2,177
)
(1,935
)
Deferred revenue
(3,820
)
(5,368
)
Net cash used in operating activities
(26,754
)
(25,954
)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of internal-use software costs
(4,806
)
(5,539
)
Purchases of marketable securities
(405,235
)
(443,307
)
Maturities of marketable securities
299,467
432,267
Purchases of property and equipment
(1,429
)
(186
)
Net cash used in investing activities
(112,003
)
(16,765
)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock upon exercise of vested options
16,606
14,401
Proceeds from issuance of common stock under employee stock purchase plan
14,195
15,603
Net cash provided by financing activities
30,801
30,004
Effect of exchange rate changes on cash and cash equivalents
537
(673
)
Net decrease in cash and cash equivalents
(107,419
)
(13,388
)
Cash and cash equivalents at beginning of period
385,980
349,761
Cash and cash equivalents at end of period
$
278,561
$
336,373
Expand
Confluent, Inc.
Reconciliation of GAAP Measures to Non-GAAP Measures
(in thousands, except percentages, share and per share data)
(unaudited)
Three Months Ended March 31,
2025
2024
Reconciliation of GAAP total gross profit to non-GAAP total gross profit:
Total gross profit on a GAAP basis
$
202,002
$
156,016
Total gross margin on a GAAP basis
74.5
%
71.8
%
Add: Stock-based compensation-related charges
10,575
10,623
Add: Amortization of acquired intangibles
461
502
Non-GAAP total gross profit
$
213,038
$
167,141
Non-GAAP total gross margin
78.6
%
76.9
%
Reconciliation of GAAP operating expenses to non-GAAP operating expenses:
Research and development operating expense on a GAAP basis
$
116,801
$
97,571
Research and development operating expense as a percentage of total revenue on a GAAP basis
43.1
%
44.9
%
Less: Stock-based compensation-related charges
43,835
41,424
Less: Acquisition-related expenses
9,641
4,362
Non-GAAP research and development operating expense
$
63,325
$
51,785
Non-GAAP research and development operating expense as a percentage of total revenue
23.4
%
23.8
%
Sales and marketing operating expense on a GAAP basis
$
146,259
$
131,352
Sales and marketing operating expense as a percentage of total revenue on a GAAP basis
53.9
%
60.5
%
Less: Stock-based compensation-related charges
32,757
35,780
Less: Acquisition-related expenses
1,076
-
Non-GAAP sales and marketing operating expense
$
112,426
$
95,572
Non-GAAP sales and marketing operating expense as a percentage of total revenue
41.5
%
44.0
%
General and administrative operating expense on a GAAP basis
$
40,120
$
38,444
General and administrative operating expense as a percentage of total revenue on a GAAP basis
14.8
%
17.7
%
Less: Stock-based compensation-related charges
14,410
15,158
Less: Acquisition-related expenses
14
225
Non-GAAP general and administrative operating expense
$
25,696
$
23,061
Non-GAAP general and administrative operating expense as a percentage of total revenue
9.5
%
10.6
%
Three Months Ended March 31,
2025
2024
Reconciliation of GAAP operating loss to non-GAAP operating income (loss):
Operating loss on a GAAP basis
$
(101,178
)
$
(111,351
)
GAAP operating margin
(37.3
%)
(51.3
%)
Add: Stock-based compensation-related charges
101,577
102,985
Add: Amortization of acquired intangibles
461
502
Add: Acquisition-related expenses
10,731
4,587
Non-GAAP operating income (loss)
$
11,591
$
(3,277
)
Non-GAAP operating margin
4.3
%
(1.5
%)
Reconciliation of GAAP net loss to non-GAAP net income:
Net loss on a GAAP basis
$
(67,574
)
$
(92,967
)
Add: Stock-based compensation-related charges
101,577
102,985
Add: Amortization of acquired intangibles
461
502
Add: Acquisition-related expenses
10,731
4,587
Add: Amortization of debt issuance costs
945
953
Add: Income tax effects and adjustments (1)
(17,156
)
(260
)
Non-GAAP net income
$
28,984
$
15,800
Non-GAAP net income per share, basic
$
0.09
$
0.05
Non-GAAP net income per share, diluted
$
0.08
$
0.05
Weighted-average shares used to compute non-GAAP net income per share, basic
335,755,902
314,203,181
Weighted-average shares used to compute non-GAAP net income per share, diluted
367,802,218
350,195,868
(1) Income tax effects and adjustments for the three months ended March 31, 2025 includes an adjustment for the income tax benefit from the release of a valuation allowance on certain deferred tax assets.
Expand
The following table presents a reconciliation of free cash flow to net cash used in operating activities, the most directly comparable GAAP measure, for each of the periods indicated (unaudited, in thousands, except percentages):
Three Months Ended March 31,
2025
2024
Net cash used in operating activities
$
(26,754
)
$
(25,954
)
Capitalized internal-use software costs
(4,806
)
(5,539
)
Capital expenditures
(1,429
)
(186
)
Free cash flow
$
(32,989
)
$
(31,679
)
Impact from compensation payments adjustment (1)
37,930
-
Adjusted free cash flow
$
4,941
$
(31,679
)
Net cash used in operating activities as a percentage of total revenue
(9.9
%)
(11.9
%)
Free cash flow margin
(12.2
%)
(14.6
%)
Adjusted free cash flow margin
1.8
%
(14.6
%)
Net cash used in investing activities
$
(112,003
)
$
(16,765
)
Net cash provided by financing activities
$
30,801
$
30,004
(1) Represents an adjustment to reflect the non-recurring impact in the first quarter of 2025 from the change to timing of cash compensation payments for most of our non go-to-market employees implemented at the start of 2025.
Expand

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nucor (NUE) Exceeds Market Returns: Some Facts to Consider
Nucor (NUE) Exceeds Market Returns: Some Facts to Consider

Yahoo

time22 minutes ago

  • Yahoo

Nucor (NUE) Exceeds Market Returns: Some Facts to Consider

In the latest market close, Nucor (NUE) reached $124.68, with a +1.75% movement compared to the previous day. This move outpaced the S&P 500's daily gain of 0.55%. On the other hand, the Dow registered a gain of 0.25%, and the technology-centric Nasdaq increased by 0.63%. Prior to today's trading, shares of the steel company had gained 2.01% over the past month. This has lagged the Basic Materials sector's gain of 4.58% and the S&P 500's gain of 6.29% in that time. The investment community will be closely monitoring the performance of Nucor in its forthcoming earnings report. In that report, analysts expect Nucor to post earnings of $2.21 per share. This would mark a year-over-year decline of 17.54%. Meanwhile, our latest consensus estimate is calling for revenue of $8.28 billion, up 2.55% from the prior-year quarter. For the full year, the Zacks Consensus Estimates project earnings of $7.88 per share and a revenue of $31.48 billion, demonstrating changes of -11.46% and +2.43%, respectively, from the preceding year. Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Nucor. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Nucor currently has a Zacks Rank of #3 (Hold). Investors should also note Nucor's current valuation metrics, including its Forward P/E ratio of 15.54. This valuation marks a premium compared to its industry's average Forward P/E of 10.69. Investors should also note that NUE has a PEG ratio of 0.78 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As the market closed yesterday, the Steel - Producers industry was having an average PEG ratio of 0.94. The Steel - Producers industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 68, which puts it in the top 28% of all 250+ industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Nucor Corporation (NUE) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo

time22 minutes ago

  • Yahoo

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., June 11, 2025--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on June 10, 2025, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 115,620 shares of common stock and 57,740 restricted stock units ("RSUs") to 10 new employees under Mirum's 2020 Inducement Plan. The Compensation Committee of Mirum's Board of Directors approved the awards as an inducement material to the new employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has an exercise price per share equal to $48.98 per share, Mirum's closing trading price on June 10, 2025, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The RSUs will vest over three years, with 33% of the underlying shares vesting on each anniversary of the applicable vesting commencement date, subject to the new employees' continued service relationship with Mirum through the applicable vesting dates. The awards are subject to the terms and conditions of Mirum's 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant. About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder. To learn more about Mirum, visit and follow Mirum on Facebook, LinkedIn, Instagram and X. View source version on Contacts Investor Contact: Andrew McKibbenir@ Media Contact: Erin Murphymedia@

Musk Vs. Trump: Poll Says This Is The Person To Support In Feud, While Near Majority Say They Would Publicly Support Neither
Musk Vs. Trump: Poll Says This Is The Person To Support In Feud, While Near Majority Say They Would Publicly Support Neither

Yahoo

time28 minutes ago

  • Yahoo

Musk Vs. Trump: Poll Says This Is The Person To Support In Feud, While Near Majority Say They Would Publicly Support Neither

A highly public feud between Tesla Inc (NASDAQ:TSLA) CEO Elon Musk and President Donald Trump took the world by storm last week and sent shares of the electric vehicle company lower. As the feud continues on, here's a look at where Benzinga readers stand. What Happened: A back-and-forth between Musk and Trump across social media platforms saw the two well-known individuals escalate a feud related to differences on the "Big Beautiful Bill." Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — The feud comes after Musk left his White House position working for the Department of Government Efficiency to spend more time working on his other companies, such as Tesla. Benzinga recently asked readers who they side with in the battle, which includes Musk criticizing the new debt the country will take on if the bill that Trump supports is passed by Congress. "In the feud between Donald Trump and Elon Musk, who are you more likely to publicly support?" Benzinga asked. Here are the results: Neither: 44% Elon Musk: 25% Donald Trump: 17% Both: 14% The poll found that a near majority said they would publicly support neither Trump or Musk in the feud between former friends. Of the two well-known candidates, Musk received the largest support with 25% of the poll, ranking ahead of Trump at 17%.Why It's Important: Over the weekend, the battle between Musk and Trump minimized some with the Tesla CEO deleting some of his tweets that brought some claims against the current president. Tweets about ending the SpaceX Dragon program were also deleted. A battle between Trump and Musk over the long run could see many losers, including the country's space program and the launch of robotaxis, with Musk a leader in both sectors and Trump able to slow down progress made by the billionaire. Tesla stock saw its largest one-day market capitalization drop last week on the heels of the feud. Tesla stock trades up 1.61% at $299.72 at publication on Monday versus a 52-week trading range of $167.42 to $488.54. The stock has fallen 15% over the last five days and is down 22% year-to-date in 2025. Read Next: Are you rich? Here's what Americans think you need to be considered wealthy. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? The study was conducted by Benzinga from June 5, 2025, through June 9, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 259 adults. Photo: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Musk Vs. Trump: Poll Says This Is The Person To Support In Feud, While Near Majority Say They Would Publicly Support Neither originally appeared on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store